Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarclisa
Pharma
Sanofi's Sarclisa SC, delivered by on-body injector, matches IV
Two trials have shown Sanofi's Sarclisa investigational SC delivered from an on-body injector produced similar efficacy and safety as Sarclisa IV.
Kevin Dunleavy
Jun 3, 2025 8:15am
Sanofi's subQ version of Sarclisa measures up to its IV version
Jan 9, 2025 11:14am
J&J counters Sanofi's Sarclisa nod with Darzalex data drop
Sep 27, 2024 3:59pm
Sanofi moves on J&J's Darzalex in first-line myeloma with FDA nod
Sep 20, 2024 4:06pm
ASCO: Sanofi's Sarclisa looks to step out of J&J's myeloma shadow
Jun 3, 2024 4:00pm
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Dec 12, 2023 12:00pm
